UK markets closed

Oramed Pharmaceuticals Inc. (ORMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3000-0.0300 (-1.29%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/08/2021
31/08/2020
Assets
Current assets
Cash
Cash and cash equivalents
9,055
40,464
77,245
19,296
Other short-term investments
152,992
115,256
16,895
20,604
Total cash
162,047
155,720
94,140
39,900
Other current assets
537
1,389
1,197
611
Total current assets
162,584
157,109
95,337
40,511
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,567
1,802
932
176
Net property, plant and equipment
1,567
1,802
932
176
Equity and other investments
54,926
2,700
6,692
3,928
Total non-current assets
57,967
4,533
32,662
4,122
Total assets
220,551
161,642
127,999
44,633
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
51,013
-
-
-
Accounts payable
551
2,175
2,606
594
Accrued liabilities
1,058
1,983
1,186
1,105
Deferred revenues
0
1,340
2,703
2,703
Total current liabilities
53,214
5,746
6,679
4,536
Non-current liabilities
Deferred tax liabilities
11
11
11
11
Deferred revenues
4,000
4,000
4,244
6,947
Other long-term liabilities
63
61
124
211
Total non-current liabilities
4,444
4,740
4,803
7,218
Total liabilities
57,658
10,486
11,482
11,754
Stockholders' equity
Common stock
485
476
424
284
Retained earnings
-157,556
-163,081
-114,852
-92,614
Total stockholders' equity
163,821
151,812
115,773
32,879
Total liabilities and stockholders' equity
220,551
161,642
127,999
44,633